Brevan Howard Capital Management LP

Q2 2017 13F Holdings Report, Stock Holdings

Signature - Title: Nigel Lawrence - Authorised Signatory
Location: St. Helier
Holdings as of: 30 Jun 2017
Value $: $19,724,000
Num holdings: 3
Filing time: 14 Aug 2017, 16:29:03 UTC
Form type: 13F-HR
Description: All US holdings of this investor are reported in this report. Top holdings included CME, LQD, and CBLAQ.
Previous filing: Q1 2017 - 15 May 2017
Next filing: Q3 2017 - 14 Nov 2017
SEC: View on sec.gov
Options Holdings: Showing stock holdings, see here for options holdings

Sym	Weight	Trade Impact	Company	Class	Share Change	Activity	Value Change $	Value $	* Price $	Shares	Principal

Filing 2017 Q2 compared to 2017 Q1 by default. Changes are calculated vs the previous SEC filing.

Compare Q2 2017 to

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name	Title	City, State	Date
Nigel Lawrence	Authorised Signatory	St Helier, Jersey	14 Aug 2017

*NOTE: THE INVESTMENT MANAGER FILING THIS REPORT IS DEEMED TO HAVE INVESTMENT DISCRETION WITH RESPECT TO SECURITIES OVER WHICH BREVAN HOWARD (HONG KONG) LIMITED ("BHHK"), BREVAN HOWARD INVESTMENT PRODUCTS LIMITED ("BHIPL"), BREVAN HOWARD ASSET MANAGEMENT LLP ("BHAM"), BREVAN HOWARD US INVESTMENT MANAGEMENT LP ("BHUS"), BREVAN HOWARD (ISRAEL) LTD. ("BH ISRAEL"), AND BREVAN HOWARD PRIVATE LIMITED ("BHPL") SUBSIDIARIES OF THE INVESTMENT MANAGER, EXERCISE INVESTMENT DISCRETION AS A RESULT OF THE INVESTMENT MANAGER HAVING CONTROL OVER BHHK, BHIPL, BHAM, BHUS, BH ISRAEL, AND BHPL.